Identification of HNPCC by molecular analysis of colorectal and endometrial tumors

Disease Markers

Volumn 20, Issue 4-5, 2004, Pages 207-213

  Vasen, H F A ^a,b   Hendriks, Y ^a   De Jong, A E ^a,b   Van Puijenbroek, M ^a   Tops, C ^a   Brocker Vriends A H J T ^a   Wijnen, J Th ^a   Morreau, H ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Netherlands Found Detection H   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

MISMATCH REPAIR PROTEIN PMS2; PROTEIN MLH1; PROTEIN MSH2; PROTEIN MSH6;

COLORECTAL CANCER; COLORECTAL TUMOR; CONFERENCE PAPER; CONTROLLED STUDY; CORRELATION ANALYSIS; COST EFFECTIVENESS ANALYSIS; ENDOMETRIUM CANCER; GENE EXPRESSION; GENE MUTATION; GENETIC PROCEDURES; HUMAN; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MICROSATELLITE INSTABILITY; MISMATCH REPAIR; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 12844266901     PISSN: 02780240     EISSN: None     Source Type: Journal    
DOI: 10.1155/2004/391039     Document Type: Conference Paper

References (31)

1. M.L. Slattery and R.A. Kerber, Family history of cancer and colon cancer risk: the Utah Population Database, J Natl Cancer Inst 86(21) (1994), 1618-1626.
2. H.T. Lynch and C.A. de la, Hereditary colorectal cancer, N Engl J Med 348(10) (2003), 919-932.
3. L.A. Aaltonen, R. Salovaara, P. Kristo, F. Canzian, A, Hemininki and P. Peltomaki et al., Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease, N Engl J Med 338(21) (1998), 1481-1487.
4. H.F. Vasen, J.T. Wijnen, F.H. Menko, J.H. Kleibeuker, B.C. Taal and G. Griffioen et al., Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis, Gastroenterology 110(4) (1996), 1020-1027.
5. M. Aarnio, R. Sankila, E. Pukkala, R. Salovaara, L.A. Aaltonen, C.A. de la et al., Cancer risk in mutation carriers of DNA-mismatch-repair genes, Int J Cancer 81(2) (1999), 214-218.
6. H.F. Vasen, A. Stormorken, F.H. Menko, F.M. Nagengast, J.H. Kleibeuker and G. Griffioen et al., MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers: a study of hereditary nonpolyposis colorectal cancer families, J Clin Oncol 19(20) (2001), 4074-4080.
7. M. Shashidharan, T. Smyrk, K.M. Lin, C.A. Ternent, A.G. Thorson, G.J. Blatchford et al., Histologic comparison of hereditary nonpolyposis colorectal cancer associated with MSH2 and MLH1 and colorectal cancer from the general population, Dis Colon Rectum 42(6) (1999), 722-726.
8. H.F. Vasen, J.P. Mecklin, P.M. Khan and H.T. Lynch, The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC), Dis Colon Rectum 34(5) (1991), 424-425.
9. H.F. Vasen, P. Watson, J.P. Mecklin and H.T. Lynch, New clinical criteria for hereditary nonpolyposis colorectal cancer (HN-PCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC, Gastroenterology 116(6) (1999), 1453-1456.
10. M.A. Rodriguez-Bigas, C.R. Boland, S.R. Hamilton, D.E. Henson, J.R. Jass and P.M. Khan et al., A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: meeting highlights and Bethesda guidelines, J Natl Cancer Inst 89(23) (1997), 1758-1762.
11. S.N. Thibodeau, G. Bren and D. Schaid, Microsatellite instability in cancer of the proximal colon, Science 260(5109) (1993), 816-819.
12. L.A. Aaltonen, P. Peltomaki, F.S. Leach, P. Sistonen, L. Pylkkanen and J.P. Mecklin et al., Clues to the pathogenesis of familial colorectal cancer, Science 260(5109) (1993), 812-816.
13. Y. Ionov, M.A. Peinado, S. Malkhosyan, D. Shibata and M. Perucho, Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonie carcinogenesis, Nature 363(6429) (1993), 558-561.
14. T.M. Wilson, A. Ewel, J.R. Duguid, J.N. Eble, M.K. Lescoe and R. Fishel et al., Differential cellular expression of the human MSH2 repair enzyme in small and large intestine, Cancer Res 55(22) (1995), 5146-5150.
15. F.S. Leach, K. Polyak, M. Burrell, K.A. Johnson, D. Hill and M.G. Dunlop et al., Expression of the human mismatch repair gene hMSH2 in normal and neoplastic tissues, Cancer Res 56(2) (1996), 235-240.
16. S.N. Thibodeau, A.J. French, P.C. Roche, J.M. Cunningham, D.J. Tester and N.M. Lindor et al., Altered expression of hMSH2 and hMLH1 in tumors with microsatellite instability and genetic alterations in mismatch repair genes, Cancer Res 56(21) (1996), 4836-4840.
17. H.P. Wullenweber, C. Sutter, F. Autschbach, F. Willeke, P. Kienle and A. Benner et al., Evaluation of Bethesda guidelines in relation to microsatellite instability, Dis Colon Rectum 44(9) (2001), 1281-1289.
18. J. Plaschke, S. Kruger, S. Pistorius, F. Theissig, H.D. Saeger and H.K. Schackert, Involvement of hMSH6 in the development of hereditary and sporadic colorectal cancer revealed by immunostaining is based on germline mutations, but rarely on somatic inactivation, Int J Cancer 97(5) (2002), 643-648.
19. Y. Hendriks, P. Franken, J.W. Dierssen, W. De Leeuw, J. Wijnen and E. Dreef et al., Conventional and tissue microarray immunohistochemical expression analysis of mismatch repair in hereditary colorectal tumors, Am J Pathol 162(2) (2003), 469-477.
20. A.E. De Jong, M. Van Puijenbroek, C. Tops, J. Wijnen, M.G.E.M. Aussems and E.H. Meijers-Heijboer et al., Results of MSI and IHC analysis of a large sereis of Dutch families suspected of HNPCC, Clin Cancer Research (2004), in press.
21. Y. Hendriks, A. Wagner, H. Morreau, F. Menko, A. Stormorken and F. Quehenberger et al., Cancer risk in hereditary nonpolyposis colorectal cancer associated with MSH6 mutations:consequences for counselling and surveillance, Gastroenterology (2004), in press.
22. A. Loukola, R. Salovaara, P. Kristo, A.L. Moisio, H. Kaariainen and H. Ahtola et al., Microsatellite instability in adenomas as a marker for hereditary nonpolyposis colorectal cancer, Am J Pathol 155(6) (1999), 1849-1853.
23. H. Iino, L. Simms, J. Young, J. Arnold, I.M. Winship, S.I. Webb et al., DNA microsatellite instability and mismatch repair protein loss in adenomas presenting in hereditary non-polyposis colorectal cancer, Gut 47(1) (2000), 37-42.
24. A.E. De Jong, H. Morreau, M. Van Puijenbroek, P.H. Eilers, J. Wijnen and F.M. Nagengast et al., The role of mismatch repair gene defects in the development of adenomas in patients with HNPCC, Gastroenterology 126(1) (2004), 42-48.
25. Y.R. Parc, K.C. Halling, L.J. Burgart, S.K. McDonnell, D.G. Schaid and S.N. Thibodeau et al., Microsatellite instability and hMLH1/hMSH2 expression in young endometrial carcinoma patients: associations with family history and histopathology, Int J Cancer 86(1) (2000), 60-66.
26. M.J. Berends, Y. Wu, R.H. Sijmons, S.T. van der, W.B. Ek and M.J. Ligtenberg et al., Toward new strategies to select young endometrial cancer patients for mismatch repair gene mutation analysis, J Clin Oncol 21(23) (2003), 4364-4370.
27. W.J. de Leeuw, J. Dierssen, H.F. Vasen, J.T. Wijnen, G.G. Kenter and H. Meijers-Heijboer et al., Prediction of a mismatch repair gene defect by microsatellite instability and immunohistochemical analysis in endometrial tumours from HNPCC patients, J Pathol 192(3) (2000), 328-335.
28. M.J. Berends, Y. Wu, R.H. Sijmons, R.G. Mensink, S.T. van der and J.M. Hordijk-Hos et al., Molecular and clinical characteristics of MSH6 variants: an analysis of 25 index carriers of a germline variant, Am J Hum Genet 70(1) (2002), 26-37.
29. J. Young, L.A. Simms, K.G. Biden, C. Wynter, V. Whitehall and R. Karamatic et al., Features of colorectal cancers with high-level microsatellite instability occurring in familial and sporadic settings: parallel pathways of tumorigenesis, Am J Pathol 159(6) (2001), 2107-2116.
30. C.M. Ribic, D.J. Sargent, M.J. Moore, S.N. Thibodeau, A.J. French and R.M. Goldberg et al., Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer, N Engl J Med 349(3) (2003), 247-257.
31. W. de Vos tot Nederveen Cappel, h. Meulebeld, J.H. Kleibeuker, F.M. Nagengast, F.H. Menko, G. Griffioen, A. Cats, H. Morreau, H. Gelderblom and H.F.A. Vasen, Survival after adjuvant 5-FU treatment for Stage III colon cancer in hereditary non polyposis colorectal cancer, Int J Cancer (2004), in press.